Teva Pharmaceutical Industries Ltd, GENOMMA LAB, and GlaxoSmith Kline plc were Dominating the Mexico Hemorrhoids Treatment Market in 2021

Mexico Hemorrhoids Treatment Market is expected to grow with the CAGR of 6.9% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/mexico-hemorrhoids-treatment-market

Mexico hemorrhoids treatment market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Mexico hemorrhoids treatment market are introducing strong range of medicines provider along with launching new medicines and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In March 2020, Teva Pharmaceutical Industries Ltd., announced the acquisition of Representaciones e Investigaciones Médicas, S.A. de C.V. (“Rimsa”), a pharmaceutical manufacturing and distribution company in Mexico, for USD 2300 million, in a cash free, debt free set of transactions. The company financed the transaction using cash on hand. This has increased the presence of the company in Mexico and will generate the revenue for the company.

Teva Pharmaceutical Industries Ltd. is the dominating player in Mexico hemorrhoids treatment market. The other key players existing in the market includes GENOMMA LAB, Glaxosmith Kline plc, Abbott, Abbvie Inc., Perrigo Company Plc, Sanofi, Bayer AG. Chinoin, Medtronic plc, Procter & Gamble, Pfizer Inc, Sandoz AG (A division of Novartis AG), Fresenius Kabi Mexico, S.A. de C.V. (A Subsidiary of Fresenius Kabi) among others

Mexico Hemorrhoids Treatment MarketTEVA PHARMACEUTICAL INDUSTRIES LTD

Teva Pharmaceutical Industries Ltd is headquartered in Pennsylvania, U.S and was founded in 1901. The company operates as a single business segment. The company has wide product portfolio including generics medication, biopharmaceuticals and specialty medicines are the market focused products.

  • In 2022 March, Teva Pharmaceutical Industries Ltd., announced the acquisition of Representaciones e Investigaciones Médicas, S.A. de C.V. (“Rimsa”), a pharmaceutical manufacturing and distribution company in Mexico, for USD 2300 million, in a cash free, debt free set of transactions. The company financed the transaction using cash on hand. This has increased the presence of the company in Mexico and will generate the revenue for the company

The company has presence in North America, Europe, Asia-Pacific, South America, and Middle East and Africa. The company has various subsidiaries such as Actavis, Pliva, Cephalon, Barr Pharmaceuticals, Ratiopharm, and Teva Canada among others

GENOMMA LAB

GENOMMA LAB was founded in 1996 and it is headquartered in Álvaro Obregón Mayor's Office, Mexico City. The company is focused in developing pharmaceutical and personal care products for Mexico and international marketing. The company deals in the over-the-counter, personal care as the business segment and over-the-counter is the market focused business segment. The company is engaged in providing wide range of products such as hydration, pain, skin, flu, hair, hemorrhoids, intimate health, infants, migraine, feet, baldness, imperfections, skin, dandruff, and cough in which haemorrhoids is the market focused products.

The company is present in North America, South America.

GLAXOSMITH KLINE PLC

GlaxoSmith Kline plc was founded in 1715 and is headquartered in Brentford, U.K. The company is focused to become one of the best company in the field of innovation, development of drugs and vaccines that will be beneficial to both patient and consumers. The company deals in the pharmaceuticals, vaccines, and consumer Healthcare as the business segment and consumer healthcare is the market focused business segment. The company is engaged in providing wide range of products such as prescription medicines, vaccines, consumer healthcare products, healthcare and stiefel dermatology in which consumer healthcare is the market focused products.

The company is present in North America, Europe, Asia-Pacific, Middle-East & Africa and South America. GlaxoSmithKline Pharmaceuticals Ltd (India), Tesaro (U.S.), GlaxoSmithKline Pakistan (Pakistan), Stiefel Laboratories (U.S.), Allen & Hanburys (U.K.), among others are some of the subsidiaries of the company.